SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " sid " 33,344 found 🔀 AI-powered Shuffle
Smart voices in business react to Apple and Xbox price hikes
After Apple and Microsoft's Xbox raised prices due to a shortage of memory chips, tech observers are not optimistic about future prices.
Mark Cuban urged AI firms to spend billions on cities hit by job losses
He said this is the "cost of doing business" for the companies that are losing a PR battle with the masses.
Will Red Grooms' whimsical, wonderful Tennessee Fox Trot Carousel ride again?
The Tennessee State Museum in Nashville is considering how to bring a beloved whimsical carousel back to life. The Tennessee Fox Trot Carousel was the creation of Nashville-born artist Red
UFC Baku early weigh ins results
Ultimate Fighting Championship (UFC) will stage its early and official weigh ins at 9 a.m. local time for this weekend’s UFC Baku mixed martial arts (MMA) event on Paramount+. Unfortunately for stateside fight fans, Baku is eight hours ahead of Eastern Standard Time, so most of us will be asleep by the time the first […]
Senate Indian Affairs Committee Advances Mark Cruz’s Nomination to Lead Indian Health Service
U.S. Senator Lisa Murkowski (R-Alaska), Chair of the Senate Committee on Indian Affairs, led a nomination hearing to consider Mr. Mark Cruz, of Oregon, to be Director of the Indian Health Service within the U.S. Department of Health and Human Services and expressed her intent to support his nomination. Representative Tom Cole (R-Okla.), a citizen […]
Twin City Entertainment collaboration to host the Carol Burrnett Show in West Monroe June 27th
WEST MONROE, La. (KTVE/KARD) — Residents in the West Monroe area will have the chance to enjoy a night of laughter later this week as a live stage production inspired by The Carol Burnett Sho…
Trump's DOT clears a pedal-free path for Tesla and Zoox
The NHTSA is proposing allowing the removal of pedals and steering wheels for AVs, making it easier for Tesla and Zoox to pursue alternative designs.
Vance dismisses Watergate scandal, says ‘deep state’ went after Nixon
The vice president said he admired Nixon and drew parallels between the past president, who resigned amid pressure in 1974, and Trump today.
Trump nominates Chris Klomp as HHS second-in-command
President Donald Trump on Thursday named Medicare director and former health care executive Chris Klomp to be deputy secretary of the US Department of Health and Human Services.
It's Xbox's turn (again), as console prices keep going up
Microsoft announced a price hike for the Xbox Series consoles today, the third in little over a year. Effective August 1, the Xbox Series S, which launched in 2020 for $300, will cost $500 in the U.S. The Xbox Series X, which launched in 2020 at $500, will go for $800. This follows a round of PlayStation 5 price increases from Sony this spring, and a slow-motion increase for Nintendo’s Switch 2, which will kick in in the U.S. in September. (Mind you, there were also eight video game industry price hikes in six months of 2025). The chart up top shows the sudden ascent of console prices over the past year, a sudden surge in an already unusual hardware generation. Prices had been flat for years, now “up” is the new “flat.” Game console prices used to go down across the length of a console generation, but not this time around. Microsoft’s explanation for the new price hike today: We hoped another price increase would not be necessary, and we have spent the last several months working with suppliers on options. Unfortunately, console storage and memory prices have increased by more than 2.5x and we expect another doubling by the fall of 2027. The entire consumer electronics industry is struggling with the current components crisis, but the effects are particularly hard on consoles. Unlike phones, computers, speakers, and other consumer devices, consoles are typically not sold at a profit, but instead for less than they cost to make. This is an issue well beyond game consoles. Apple announced price hikes on its computers and tablets today as well. Game File is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe Item 2: Brutal Bungie cuts Bungie laid off “most” of its Destiny development team and some developers who worked on Marathon, the newest game from the struggling Sony-owned studio. A WARN notice issued by Sony to Washington State, where Bungie is based, tallied cuts impacting 292 workers, effective next month. That’s strictly for Bungie/Sony jobs in Washington and wouldn’t account for any elsewhere. The video I clipped below shows the redacted list of Bungie cuts filed to Washington State officials. As you’ll see, I had to scroll for a while… In a note emailed to PlayStation workers and published online, PlayStation game studios chief Hermen Hulst offered the following explanation for these latest cuts at Bungie: This is painful news, especially for talented colleagues whose roles have been eliminated. This decision was made only after extensive discussion and careful consideration, and I want to provide some context on how we arrived here. Over the past several months, together with Bungie leadership, we reviewed the studio’s long-term direction, development priorities, resource needs, and role within our broader portfolio strategy. We explored multiple alternatives before concluding that a reduction was necessary to align the studio’s resources with its current priorities and long-term goals. In 2022, Sony bought Bungie for $3.7 billion. The studio’s marquee game, the multiplayer live service shooter Destiny 2 was losing popularity at the time. Its next game Marathon, released earlier this year, has been well-reviewed but had a slow start. Bungie is renowned for making great shooter games, and Destiny fans have mourned the wind-down of Destiny 2. They’ve also expressed bewilderment over reports that Destiny 3 is not, per Bloomberg, immediately in the cards.
JD Vance says Nixon’s Watergate scandal would be ‘12-hour news story’ today
Vice-president declares admiration for 37th president and claims Nixon and Trump targeted by ‘deep state’ forces
Vice President JD Vance talks faith and politics in Orange County
Vance largely talked about his grandmother’s influence at the sold-out event, which came on the heels of his new memoir, “Communion: Finding My Way Back to Faith.”
Baxter Health Heart and Vascular Clinic Welcomes Brandi Watson, APRN
Baxter Health is proud to welcome Brandi Watson, APRN, to the Baxter Health Heart and Vascular Clinic. Watson joined the team on May 15 and is currently accepting new patients. Watson brings more than 25 years of experience caring for some of the most critically ill patients. Much of her career has been spent in intensive care settings, where she learned to make fast, high-stakes decisions for patients whose lives depended on getting the right care at the right moment. That kind of experience, which is gained through years at the bedside, is exactly what heart and vascular patients need from a provider.
Behavioral Healthcare Close to Home: SRMC Services Available in Sandoval County
Sandoval County spans more than 3,000 square miles with a population of 160,000 residents. As one of New Mexico’s fastest growing counties, it’s crucial the people who live there have access to high quality healthcare, including behavioral health...
JD Vance claims Diddy is 'not a Christian' after federal conviction
Sean "Diddy" Combs might have scored a reference in Vice President JD Vance's new book, but the politician is not eager to associate himself with the imprisoned music mogul.
Trump nominates new top deputy to RFK Jr.
Chris Klomp, a 45-year-old tech entrepreneur, gained the president's confidence when he negotiated price cuts with drug companies.
2026 World Cup Is Putting FIFA’s Rules on Political Neutrality to the Test
The World Cup is in full swing across North America, and the U.S. men’s team faces Turkey in its final group round appearance on Thursday. But behind the cheering fans and nail biting matches, FIFA's commitment to political neutrality is put to the test. Marisa sits down with Tariq Panja, global sports correspondent at The New York Times. They dig into the politics behind the games, from restrictions on Iran’s team and President Trump’s unusually close relationship with FIFA president Giann
Trump will present the World Cup trophy. It could be VERY awkward
The president has launched a war with nation in the tournament, and a war of words with many others.
President Trump Signs Executive Order Advancing Regenerative Agriculture as Part of Make America Healthy Again Agenda
President Trump Signs Executive Order Advancing Regenerative Agriculture as Part of Make America Healthy Again Agenda
Vance, an admirer of Richard Nixon, says Watergate would be 'a 12-hour news story' today
Vice President JD Vance says the Watergate scandal that brought down President Richard Nixon would have been a blip in today’s news cycle
Serious statin side effects on muscles are extremely rare, new research confirms
Scientists created a new tool to help doctors predict a patient’s risk of severe muscle problems from taking a statin.
The Business of Beauty Global Forum: Inside the Industry
Jane Hertzmark Hudis, Simone Dominici and Vicky Tsai were among the speakers unpacking the most pressing topics for the industry in the second session of The Business of Beauty Global Forum 2026.
Inside Trump’s plans for retribution and other lesser-known allegations in ‘Regime Change’
A new book from two Washington reporters reveals what took place inside the White House after President Donald Trump’s return to power.
City council members request special meeting on planned Sports and Entertainment District
San Antonio Council Districts 1, 5 and 7 want a special meeting before Aug. 7 to guide public input on the Spurs arena’s $75M Community Benefits Agreement as the city considers a $489M Sports and Entertainment District.
Monkey Business: Wild rhesus macaque spotted at Mount Dora hotel
A wild rhesus macaque was spotted at the historic Lakeside Inn in Mount Dora, Florida, spending about 45 minutes roaming the property and attracting attention from guests and staff. The hotel and local businesses responded with humorous, monkey-themed social media content, engaging the community. Wildlife officials cautioned the public not to approach or feed wild monkeys due to potential health risks and encouraged reporting sightings to authorities. The monkey has not returned to the hotel but has been seen elsewhere in downtown Mount Dora.
Yearslong Resident Evil mystery solved: Kyle MacLachlan revealed to be Jill Valentine's 'boyfriend'
Twin Peaks star has ties to STARS
Justices Clash on Whether Race Played a Role in Trump’s Bid to Deport Haitians
The split mirrored one that has long divided Americans: how seriously to take the president’s loose, provocative and sometimes ugly remarks.
Michigan president has strong words for college sports after Dusty May exit
Michigan president Domenico Grasso spoke with Dusty May and said he cited the transfer portal and uncertainty about NIL as reasons for his departure.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Inside the Oregon coast's hands-on marine science center
The Charleston Marine Life Center offers touch tanks, whale skeletons and hands-on exhibits while connecting visitors with marine science on the Oregon coast.
How many professional sports teams are in Austin?
With all the buzz around bringing more professional sports teams to the metro area, it’s worth considering how many are already here.
Who is Anuk Karunaratne? Meet the Cardinals’ new President of Business Operations
The St. Louis Cardinals formally promoted Anuk Karunaratne to the role of President of Business Operations on Wednesday as the franchise unveiled changes to its organizational leadership structure.
Trump keeps turning Republican wins into loyalty tests
President Donald Trump’s moves on housing, FISA, Iran and Washington projects are creating new headaches for Republicans trying to show voters they can govern.
Target rolls out new attendance tracking system for workers
Target's new point-based attendance tracking system rolls out in the coming months, the latest of several changes aimed at improving store operations.
Scientists measure hidden quantum forces that could power a new generation of pharmaceutical drugs
It's one thing to design a pharmaceutical drug. It's another to know if and why it actually works; not on paper or in a computer model, but inside the chaotic world of living systems, where proteins twist ...
Takeaways: Supreme Court hands Trump massive wins on immigration agenda
The Supreme Court’s conservative majority delivered President Donald Trump a pair of significant affirmations of his immigration policy Thursday, paving the way for the administration to effectively remove more than 1 million people from the US and keep many others from entering in the first place.
Trump’s fixation on election overhaul bill derails GOP agenda on Capitol Hill
A nasty feud over President Donald Trump’s elections overhaul push has further crippled an already-dysfunctional Congress, leaving Republicans unable to move on critical elements of their agenda.
Morningside University breaks ground for new business building
On Thursday, June 25, Morningside University hosted a groundbreaking ceremony for Honeck Freymann Hall, the future home of the Rosen School of business.
Dolly Parton surprises fans at opening of her new travel stop amid ongoing health battle
Parton had to cancel her Las Vegas residency after announcing she was being treated for an undisclosed health issue.
Best Prime Day Oura Ring deals: Get a record-low price
The Oura Ring 4 is our pick for the best smart ring on the market, and it's getting an excellent Prime Day deal.
Impact of European heat wave on transportation, businesses, tourism
A heat wave across Europe caused record-breaking temperatures, affecting businesses, infrastructure, and daily life.
Supreme Court sides with weedkiller Roundup, making some MAHA activists angry
Here's what to know about health concerns surrounding glyphosate and the weedkiller Roundup following a major Supreme Court ruling.
This Week in Jacksonville: Business Edition - Tim Cost reflects on 14 years leading Jacksonville University
As Jacksonville University prepares to welcome new leadership, outgoing President Tim Cost says his focus remains on the institution’s future rather than his own legacy.
SBA’s Proposed Update to the 8(a) Business Development Program: A New Approach to Social Disadvantage
On June 11, 2026, the Small Business Administration (“SBA”) published a proposed rule that would fundamentally alter how individuals qualify as “socially
Trump Keeps Undercutting Republicans’ Message, Squandering His Own Trifecta
Divisions between the president and his party on Capitol Hill have muddled Republicans’ midterm pitch to voters, and have crippled the G.O.P. at what should be the peak of its power.
Platner, Collins’ campaign spar over federal contracts
Platner released a multi-point plan he calls “a corruption crackdown,” which covers issues such as big money in politics, lobbying activities by former members of Congress, and making it more difficult for presidents to cash in on their position while in office.
Microsoft is raising Xbox prices yet again — this time by up to $150
Microsoft said memory and storage prices have increased by "more than 2.5x" and it expects "another doubling by the fall of 2027."
Trump’s politics of emergencies leaves GOP allies scrambling again
In upending plans to sign a bipartisan housing bill, the president illustrated one of his favored tactics: declaring a policy preference to be an emergency.
Governor Mills Celebrates Groundbreaking for Youth Mental Health Treatment Facility in Saco
Saco, MAINE-- Governor Janet Mills today participated in a groundbreaking ceremony for Sweetser's new youth psychiatric residential treatment facility. Governor Mills and the Legislature secured more than $5 million to help build the treatment facility.
Graham Platner backs legal maneuver using Maine law to rein in political spending
Democratic U.S. Senate nominee Graham Platner wants to overturn the landmark U.S. Supreme Court ruling that enabled corporations and other outside groups to spend unlimited money on elections by any means possible. He supports a constitutional amendment and ethics rules on the high court, which the Sullivan oyster farmer included in his latest policy rollout […]
EARLY CHILDHOOD EDUCATION ENDOWMENT ADVISORY BOARD APPROVES HEALTH INSURANCE SUBISIDY PROGRAM FOR EARLY CHILDHOOD EDUCATORS
EARLY CHILDHOOD EDUCATION ENDOWMENT ADVISORY BOARD APPROVES HEALTH INSURANCE SUBSIDY PROGRAM FOR EARLY CHILDHOOD EDUCATORS FOR IMMEDIATE RELEASE June 25, 2026 The Early Childhood Education Endowment’s Advisory Board voted on Tuesday to approve the new early childhood educator health insurance subsidy program beginning in 2027 and available through Access Health CT open enrollment starting October 23, 2026. Established into law…
Proposed CDC science office could tighten political control at agency
Under President Trump, political leaders are exerting more control across federal health agencies.
Survey finds Roy Cooper continues to hold double digit lead in N.C. Senate race
A new survey finds former North Carolina governor Roy Cooper leading former Republican National Committee Chair Michael Whatley by double digits in the pivotal Senate race in November.
Spent 3 days at Acadia National Park; biggest mistakes we made
We spent a few days exploring Acadia National Park in Maine. Next time we go, we'll make reservations and avoid mistakes like packing the wrong shoes.
Business Briefs: June 26, 2026
Art Deviation Gallery moves GREENFIELD — Art Deviation Gallery & Store has moved from 365 Main St. to inside Whitney Hill Antiques, one-third of a mile away. Collaborators JJ White and Lee Matthew started selling items out of the 50-square-foot space they rent on Feb. 1 and closed the former location later that month. “A […]
Major part of student-loan repayment overhaul is blocked in court
A federal court ruled that the Education Department's proposed borrowing caps for advanced healthcare programs cannot take effect on July 1.
Six Female Student-Athletes Named to College Sports Communicators At Large Academic All-District Team
Springfield, Mass. – June 23, 2026 – Six Springfield College student-athletes were named to the 2026 College Sports Communicators (CSC) Academic All-District Team this year.
Federal court blocks Trump’s executive order limiting mail ballots
The ruling comes a month after another judge allowed Trump’s order to stand. The latest ruling sidelines major provisions of the order despite the earlier ruling.
Supreme Court sides with big business in Roundup cancer risk fight
The ruling is also a victory for the Trump administration and a defeat for the Make America Healthy Again movement.
Bo McCalebb Inducted into the Allstate Sugar Bowl New Orleans Sports Hall of Fame
NEW ORLEANS — Former University of New Orleans All-American guard Bo McCalebb reiterated how much he loved his time on the Lakefront as he was inducted into the Allstate Sugar Bowl's New Orleans Sports Hall of Fame on Wednesday night.
York, Community Unite for Hands-On Environmental Science Journey
A group of students, faculty, and Southeast Queens residents recently traveled from the York College campus to the waterfront campus of Kingsborough Community College (KCC) in the Manhattan Beach neighborhood of Brooklyn to set sail in the Research Vessel CUNY1 on Jamaica Bay, and to explore a part of the Hudson Raritan Estuary system.
How Elifin is reshaping the commercial real estate playbook
Elifin is leveraging a decade's worth of proprietary commercial real estate data as well as artificial intelligence to reshape how properties are marketed, analyzed and sold. The Baton Rouge-based … Already an INSIDER? Sign in. Already an INSIDER? Sign in
Supreme Court sides with big business in Roundup cancer risk fight
The ruling is also a victory for the Trump administration and a defeat for the Make America Healthy Again movement.
Photos from inside the Cannes Lions party scene: Spotify, Yahoo, more
When the sun sets on the for the day, the Cannes Lions partygoers come out to play. Ad execs said the party scene brings clout and connections.
Semi-communal 'compound houses' in Ghana affect how people participate in political activity
Could the precise architectural form of your residence influence how much you participate in politics? A new study by MIT scholars finds this to be exactly the case—at least in Accra, Ghana, where many ...
Their Family Business Went From Bankruptcy to a $4 Billion Snack Empire: Inside Jack Link’s Wild Entrepreneurial Ride
Meat, risk, and NASCAR — here's how Jack Link's CEO Troy Link has grown his family business into a global phenomenon.
Democratic socialists cemented power in New York. Next, the rest of the country?
The Democratic Socialists of America won with support outside their usual base. Winning outside New York may be a different challenge.
Apple raises Mac and iPad prices by as much as 25%
Apple CEO Tim Cook had earlier warned of price increases due to the memory chip shortage.
Protests at Sen. Collins’s office on Dobbs anniversary
Members of Indivisible Maine and supporters of Graham Platner gathered outside Sen. Susan Collins’ office on Wednesday to criticize her comment that she does “not regret” supporting Justice Brett Kavanaugh’s nomination.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
NJ Legislators Push for End to Corporate Money in Politics
NJ Legislators Push for End to Corporate Money in Politics New Legislation Would Redefine “Corporation” Under State Law to Disallow Political Spending SUMMIT, N.J.—Assemblymembers Andrew Macurdy, Chigozie Onyema, and Maureen Rowan today announced a bill that would bring an end to corporate spending on politics in New Jersey. The bill alters the definition of “corporation”[...]
Immigrant-led residential care businesses in Maine launch new coalition
The group consists of 30 agencies who provide Medicare services to Mainers with intellectual disabilities and autism.
After my divorce, I rebuilt my life, starting with friendship
After my divorce, I felt lonely and had to make new friends. I learned a lot about friendship — and myself — in the process.
Dolly Parton Makes Surprise Appearance Following Health Issues
Dolly Parton made a surprise appearance at the grand opening of her travel stop in Tennessee just one month after she canceled an upcoming Vegas residency due to health concerns.
CU Director of Sports Medicine Dr. Eric McCarty Provides Capitol Hill Briefing on College Athletics Landscape
The University of Colorado's Director of Sports Medicine Dr. Eric McCarty was among a prestigious panel of physicians and coaches leading a briefing on Capit...
Hackensack Meridian Health Graduates Largest Number of Residents and Fellows Yet for Network
314 doctors continue their quest to be the best clinicians possible within New Jersey’s largest and most comprehensive health network
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Playing soccer can score major goals for heart and brain health
Seattle, June 25, 2026 — As the global soccer championship run by the Fédération Internationale de Football Association (FIFA) plays out on stages across the world this summer, catching a fever for football (as soccer is known outside the U.S.) may...
Inside Notre Dame MBA Global Business Immersion in Santiago, Chile - Notre Dame Business Mendoza College of Business
Global MBA students gain firsthand exposure to global capital markets and international business strategy in Santiago, Chile.
Supporters of KY’s Lee Specialty Clinic supporters want politics put aside to avert cuts
Over 100 people rallied in support of Lee Specialty Clinic in Frankfort Wednesday afternoon and testified on the importance of its services.
BBC and Sidemen to host World Cup watchalong
BBC Sport and YouTube collective the Sidemen team up for a World Cup watchalong on Thursday.
Political strategist on the growing tensions between Trump and Senate Republicans
NPR's Michel Martin speaks with political strategist Alex Conant about President Trump's tense meeting with Republican senators on Capitol Hill.
Keiser's Paul Dodson Voted 2025-26 SUN Sports Information Director of the Year
The Sun Conference is pleased to announce that Keiser University Assistant Athletics Director of Communications Paul Dodson has been named the 2025-26 Sun Conference Sports Information Director of the Year, as voted on by his peers across the league. The honor marks the third conference SID of the Year award of Dodson's career after previously earning the distinction in 2022-23 at Keiser University and 2018-19 while at Johnson & Wales University.
Oakland Athletics Partners with Motion Sports
ROCHESTER, Mich. - Oakland University has announced a new partnership with Motion, the modern technology platform built for college athletic departments. The Golden Grizzlies will implement Motion across their athletic department, giving coaches, academic staff, and student-athletes a cleaner, more connected way to work.
Senate Republicans reject war powers resolution after Trump-Cassidy clash
The late-night vote came hours after a fractious meeting that included a shouting match with President Donald Trump over some senators’ opposition to the conflict.
Folarin Balogun and USMNT Transfer Updates
Hosts Tamerra Griffin and James McNicholas break down a massive six-match World Cup slate as group stages reach their climax. Soccer insider David Ornstein joins the show to discuss the escalating transfer market buzz surrounding USMNT star Folarin Balogun and Tottenham’s Lucas Bergvall. Plus, the team highlights The Athletic’s interactive World Cup Tracker with Jay Harris to map out the complicated qualification pathways for Group A, B, and C. Can the USMNT line up a favorable Round of 32 matchup? Senior Editor Hannah Vanbiber also dives into the debate surrounding Jeremy Doku’s...
Utah State Joins Mountain Pacific Sports Federation as Affiliate Member in Indoor Track & Field
LOGAN, Utah – Utah State has accepted an invitation to join the Mountain Pacific Sports Federation as an affiliate member in men's and women's indoor track & field, it was announced by the conference on Thursday. Utah State's membership in the conference will be effective on July 1.
High costs hurt Wisconsin residents’ health, state report shows
A new report from Wisconsin’s health department examining where the state is winning and losing when it comes to the health of Wisconsinites.
Australia Faces a Trumpian Turn in Politics
Pauline Hanson’s far right One Nation is no longer an outsider on the political stage.
Monterey Motorsports Festival Announces 2026 Entertainment Lineup Headlined by Viral DJ Duo SIDEQUEST
/PRNewswire/ -- The Monterey Motorsports Festival is turning up the volume for Monterey Car Week 2026 with its biggest entertainment lineup to date, featuring...
I couldn't find a job, so I'm going to nursing school at 45
A 45-year-old couldn't find a corporate job for over a year so she decided to pursue nursing school instead. She wishes she started sooner.
Trump is racing to finish his border wall. Here’s how he is planning to do it
President Donald Trump is accelerating his effort to finish his border wall and setting an ambitious goal of completing it by the end of his administration. He’ll need landowners whose property runs along the US-Mexico border to hand over their land to finish it.
Jeffrey Epstein's friends' settlements draw Congress' interest
Members of Congress have discussed issuing subpoenas to find out about the NDAs between some of Jeffrey Epstein's friends and his accusers.
Palo Alto Networks CEO: Workers are in 'Darwinian moment' with AI
"The challenge right now is 90% of the enterprise employees are not AI savvy," said Palo Alto Networks' CEO, who added that self-teaching is key.
Union issues spark conflict between Group Health Co-op and members
Changes in the Group Health bylaws have become a point of contention for members who say they are ignored by the co-op's management,
Meta's reckoning has arrived
After years of layoffs, restructuring, and hard-charging management tactics, Meta's leaders are acknowledging a collapse in employee trust and morale.
Tamworth sign duo Dyson and Bailey
National League side Tamworth sign midfielder Oliver Dyson and left-back Joshua Bailey.